Artificial Heart Lung Machines is a device used in open heart surgery to support the body during the surgical procedure while the heart is stopped. The heart-lung machine is often referred to as the “pump”, and does the work of the heart and lungs during the operation.
The classification of artificial heart lung machines includes single roller pump HLM and double roller pump HLM, and the revenue proportion of single roller pump HLM in 2016 is about 66.3%. Artificial heart lung machines can be used for cardiac surgery, lung transplant operation, acute respiratory failure treatment and other. The most proportion of artificial heart lung machines is used for cardiac surgery, and the sales proportion is about 66.2% in 2016.
North America is the largest sales place, with a sales market share nearly 36.4% in 2016. Following North America, Europe is the second largest sales place with the sales market share of 33.3%. China, Japan and Korea are also important sales regions for artificial heart lung machines.
Heart Lung Machine market is mainly occupied by large companies, Sorin as the largest player in the market produced over 57% of Artificial Heart Lung Machine and made more than 59.6% of revenue share in 2016. MAQUET followed as second produced about 18.3% in 2016.
According to this study, over the next five years the Artificial Heart Lung Machines market will register a 4.0% CAGR in terms of revenue, the global market size will reach US$ 310 million by 2024, from US$ 250 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Artificial Heart Lung Machines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Heart Lung Machines market by product type, application, key manufacturers and key regions and countries.
This study considers the Artificial Heart Lung Machines value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Single Roller Pump HLM
Double Roller Pump HLM
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Cardiac Surgery
Lung Transplant Operation
Acute Respiratory Failure Treatment
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
LivaNova (Sorin)
Getinge (Maquet)
Medtronic
Terumo CV Group
Braile Biomedica
Tianjin Medical
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Artificial Heart Lung Machines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Artificial Heart Lung Machines market by identifying its various subsegments.
Focuses on the key global Artificial Heart Lung Machines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Artificial Heart Lung Machines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Artificial Heart Lung Machines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Artificial Heart Lung Machines Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artificial Heart Lung Machines Consumption 2014-2024
2.1.2 Artificial Heart Lung Machines Consumption CAGR by Region
2.2 Artificial Heart Lung Machines Segment by Type
2.2.1 Single Roller Pump HLM
2.2.2 Double Roller Pump HLM
2.3 Artificial Heart Lung Machines Consumption by Type
2.3.1 Global Artificial Heart Lung Machines Consumption Market Share by Type (2014-2019)
2.3.2 Global Artificial Heart Lung Machines Revenue and Market Share by Type (2014-2019)
2.3.3 Global Artificial Heart Lung Machines Sale Price by Type (2014-2019)
2.4 Artificial Heart Lung Machines Segment by Application
2.4.1 Cardiac Surgery
2.4.2 Lung Transplant Operation
2.4.3 Acute Respiratory Failure Treatment
2.4.4 Others
2.5 Artificial Heart Lung Machines Consumption by Application
2.5.1 Global Artificial Heart Lung Machines Consumption Market Share by Application (2014-2019)
2.5.2 Global Artificial Heart Lung Machines Value and Market Share by Application (2014-2019)
2.5.3 Global Artificial Heart Lung Machines Sale Price by Application (2014-2019)
3 Global Artificial Heart Lung Machines by Players
3.1 Global Artificial Heart Lung Machines Sales Market Share by Players
3.1.1 Global Artificial Heart Lung Machines Sales by Players (2017-2019)
3.1.2 Global Artificial Heart Lung Machines Sales Market Share by Players (2017-2019)
3.2 Global Artificial Heart Lung Machines Revenue Market Share by Players
3.2.1 Global Artificial Heart Lung Machines Revenue by Players (2017-2019)
3.2.2 Global Artificial Heart Lung Machines Revenue Market Share by Players (2017-2019)
3.3 Global Artificial Heart Lung Machines Sale Price by Players
3.4 Global Artificial Heart Lung Machines Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Artificial Heart Lung Machines Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Artificial Heart Lung Machines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Artificial Heart Lung Machines by Regions
4.1 Artificial Heart Lung Machines by Regions
4.1.1 Global Artificial Heart Lung Machines Consumption by Regions
4.1.2 Global Artificial Heart Lung Machines Value by Regions
4.2 Americas Artificial Heart Lung Machines Consumption Growth
4.3 APAC Artificial Heart Lung Machines Consumption Growth
4.4 Europe Artificial Heart Lung Machines Consumption Growth
4.5 Middle East & Africa Artificial Heart Lung Machines Consumption Growth
5 Americas
5.1 Americas Artificial Heart Lung Machines Consumption by Countries
5.1.1 Americas Artificial Heart Lung Machines Consumption by Countries (2014-2019)
5.1.2 Americas Artificial Heart Lung Machines Value by Countries (2014-2019)
5.2 Americas Artificial Heart Lung Machines Consumption by Type
5.3 Americas Artificial Heart Lung Machines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Artificial Heart Lung Machines Consumption by Countries
6.1.1 APAC Artificial Heart Lung Machines Consumption by Countries (2014-2019)
6.1.2 APAC Artificial Heart Lung Machines Value by Countries (2014-2019)
6.2 APAC Artificial Heart Lung Machines Consumption by Type
6.3 APAC Artificial Heart Lung Machines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Artificial Heart Lung Machines by Countries
7.1.1 Europe Artificial Heart Lung Machines Consumption by Countries (2014-2019)
7.1.2 Europe Artificial Heart Lung Machines Value by Countries (2014-2019)
7.2 Europe Artificial Heart Lung Machines Consumption by Type
7.3 Europe Artificial Heart Lung Machines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Artificial Heart Lung Machines by Countries
8.1.1 Middle East & Africa Artificial Heart Lung Machines Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Artificial Heart Lung Machines Value by Countries (2014-2019)
8.2 Middle East & Africa Artificial Heart Lung Machines Consumption by Type
8.3 Middle East & Africa Artificial Heart Lung Machines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Artificial Heart Lung Machines Distributors
10.3 Artificial Heart Lung Machines Customer
11 Global Artificial Heart Lung Machines Market Forecast
11.1 Global Artificial Heart Lung Machines Consumption Forecast (2019-2024)
11.2 Global Artificial Heart Lung Machines Forecast by Regions
11.2.1 Global Artificial Heart Lung Machines Forecast by Regions (2019-2024)
11.2.2 Global Artificial Heart Lung Machines Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Artificial Heart Lung Machines Forecast by Type
11.8 Global Artificial Heart Lung Machines Forecast by Application
12 Key Players Analysis
12.1 LivaNova (Sorin)
12.1.1 Company Details
12.1.2 Artificial Heart Lung Machines Product Offered
12.1.3 LivaNova (Sorin) Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 LivaNova (Sorin) News
12.2 Getinge (Maquet)
12.2.1 Company Details
12.2.2 Artificial Heart Lung Machines Product Offered
12.2.3 Getinge (Maquet) Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Getinge (Maquet) News
12.3 Medtronic
12.3.1 Company Details
12.3.2 Artificial Heart Lung Machines Product Offered
12.3.3 Medtronic Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Medtronic News
12.4 Terumo CV Group
12.4.1 Company Details
12.4.2 Artificial Heart Lung Machines Product Offered
12.4.3 Terumo CV Group Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Terumo CV Group News
12.5 Braile Biomedica
12.5.1 Company Details
12.5.2 Artificial Heart Lung Machines Product Offered
12.5.3 Braile Biomedica Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Braile Biomedica News
12.6 Tianjin Medical
12.6.1 Company Details
12.6.2 Artificial Heart Lung Machines Product Offered
12.6.3 Tianjin Medical Artificial Heart Lung Machines Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Tianjin Medical News
...
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Artificial Heart Lung Machines
Table Product Specifications of Artificial Heart Lung Machines
Figure Artificial Heart Lung Machines Report Yea